2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice

Vincenzo Arena, Ilaria Pennacchia, Arnaldo Carbone, Fabio Maria Vecchio

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

The release of the new ASCO/CAP guideline recommendations for human epidermal growth factor receptor 2 testing has led to clearer descriptive definitions for immunohistochemistry categories. As soon as we started to use them we realized that an increase in the number of ISH test was occurring. Herein we report our lab data obtained by comparing the semester after the release of the new guidelines with the same semester of the previous year. The impact on routine work practice is highlighted.
Lingua originaleEnglish
pagine (da-a)285-286
Numero di pagine2
RivistaTHE BREAST
Volume24
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • ASCO/CAP
  • Breast Neoplasms
  • Early Detection of Cancer
  • Female
  • Guidelines
  • HER2
  • Humans
  • Neoplasm Proteins
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Receptor, ErbB-2

Fingerprint

Entra nei temi di ricerca di '2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice'. Insieme formano una fingerprint unica.

Cita questo